6-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and diabetes | Patent Number 11633403

US 11633403 B2
Application Number17362763
Publication NumberUS 20220117974 A1
Pendency1 year, 10 months
Filled DateJun 29, 2021
Priority DateFeb 17, 2017
Publication DateApr 21, 2022
Expiration DateFeb 16, 2037
Inventor/ApplicantsJessica Martinsson
Johan Lindstrom
Martin Andersson
Rickard FORSBLOM
Fredrik Rahm
Martin ANDERSSON
Tobias GINMAN
Tobias Ginman
Rickard Forsblom
Jenny Viklund
Jenny VIKLUND
Jessica MARTINSSON
Fredrik RAHM
Johan LINDSTROM
ExaminesOTTON, ALICIA L
Art Unit1699
Technology Center1600
Assignments
Sprint Bioscience Ab
Current
Sprint Bioscience Ab
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.